Welcome to our blog
Insights from our team, partnered clinicians, and leaders in the field.
This report adds detail to existing findings in wider tech sector studies that workforce diversity has stagnated, now on-par with the 1990s in relative terms within AI. We discussed the findings with Mihaela Van Der Schaar, the most-cited female AI researcher in the UK from the data set.
I dream of the day we no longer need to discuss inequalities in STEM between men and women, because they will simply not exist. That day is still too far away, resulting in a huge waste of talent and a loss to society. I want to tell you why I’m passionate about changing this situation.
The Cambridge Centre for AI in Medicine develops pioneering AI and machine learning technologies with the goal of transforming biomedical science, medicine and healthcare. Another of our goals is to bring you the very latest advances in ML for medicine, directly from the pioneers making it happen. To this end, we are excited to announce…
CCAIM Director, Professor Mihaela van der Schaar, explores the potential impacts of automated machine learning on medicine and healthcare delivery, with a message of empowerment for clinicians. Read the full story.
At the end of April 2020, CCAIM Director, Professor Mihaela van der Schaar, gave a keynote (Zoom) presentation at ICLR 2020, a key deep learning conference that draws an impressively diverse crowd of participants and speakers. She discusses key aspects of her presentation. Read the full story.
CCAIM Director, Professor Mihaela van der Schaar, explains that using AI and machine learning in medicine isn’t just about developing accurate models and rolling them out because, on their own, they are “black boxes” that are hard for their intended users to apply, understand, and trust. Professor van der Schaar presents a solution to this…
CCAIM Director, Professor Mihaela van der Schaar, calls on governments and healthcare authorities to use proven AI and machine learning techniques and existing data to coordinate a response to the covid-19 pandemic. Read the full story.